Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ACP Immunotherapy Workshop /
Managing cytokine release syndrome

13th Oct 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.10.17
Views: 1639
Rating:

Dr Charlotte Graham - King’s College London, London, UK

Dr Graham talks with ecancer at the ACP immunotherapy workshop about CRS, a side effect associated with recently approved CAR-T cell therapies.

She describes the presentation and pathways activated at the onset of cytokine release syndrome, and relates case details from one patient treated with tociluzumab and steroids.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation